Company expects sales to return to growth this year
08/02/2012
NEWS
Drug is one of several medicines Roche expects will restore revenue growth in 2012
08/02/2012
NEWS
$5.7bn offer described as "grossly inadequate"
08/02/2012
NEWS
Ute Bockstegers takes over from Stephen Waite
08/02/2012
NEWS
He joined the company last August as head of RSA Switzerland
08/02/2012
NEWS
But there are signs industry business models are adapting to cope with ‘value challenge’
07/02/2012
NEWS
Four studies of GSK'052 in patients with urinary tract and intra-abdominal infections halted as "microbiological finding" investigated
07/02/2012
NEWS
VP of translational and early drug development at Celgene joins as e-Therapeutics prepares to advance several investigational drugs into clinical trials
07/02/2012
NEWS
Spasticity treatment could launch in nine more European countries
07/02/2012
NEWS
Type 2 diabetes treatment now available for patients who cannot take metformin
07/02/2012
NEWS
Will submit orexin receptor antagonist suvorexant to the FDA later this year
07/02/2012
NEWS
Five-year collaboration with TU Dresden will also look at link between high blood sugar levels and diabetes complications
06/02/2012
NEWS
Generic version of Lilly’s Zyprexa adds almost $100m to revenues
06/02/2012
NEWS
Sucampo shares up after positive phase III trial results
06/02/2012
NEWS
Threshold Pharmaceuticals' TH-302 is in phase III trials for soft tissue sarcoma and phase II for pancreatic cancer
06/02/2012
NEWS
Rainbow Medical Engineering director to lead new discoveries and inventions at King’s College London
06/02/2012
NEWS
GMB and Unite say 350 job cuts in R&D at Chesire facility will damage UK industry, although ABPI remains optimistic
03/02/2012
NEWS
Diabetes portfolio encourages 12 per cent increase in revenues for Denmark-based firm
03/02/2012
NEWS
Gains in diabetes division, but generics pose threat for 2012
03/02/2012
NEWS
Former Savient CEO and Lilly senior VP John Johnson replaces Gold who remains at Dendreon as executive chair
03/02/2012
NEWS